Investment
Features
FeesSafety
Academy
More
Pluang+

Brave introduces AI agent payments with stablecoins and expands BAT rewards in new roadmap.

Protocol Fundamentals
19 Oct 2026
Tokenpost
View Source
Bullish
Brave introduces AI agent payments with stablecoins and expands BAT rewards in new roadmap.

Brave has launched a payment system allowing AI agents to pay for individual Search API requests using stablecoins, without needing accounts or API keys. The company's BAT Roadmap 4.0 outlines plans to expand payment support across Brave products, including a redesigned Brave Wallet, BravePay stablecoin protocol, and a Brave Rewards Card offering BAT rewards. The roadmap also proposes a Creator Contribution Protocol and plans to phase out Brave Ads Notification by 2026 while continuing other ad rewards. Brave aims to use revenue from wallet, card, and BravePay activities for BAT buybacks, with more details on BAT's role expected later this year.

Brave's expansion of stablecoin payments and BAT integration comes as a backdrop to current cryptocurrency market activity. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Oct 20, 2026 09:21 WIB: out of 50 major cryptocurrencies, 15 rose and 34 fell today. Notable movers include ADA at Rp3.912 with a 1-day change of -2.40% and a typical hold time of 127 days, LINK at Rp215.752 with a -2.39% change, and AAVE at Rp2.691.656 with 100% buy order activity and a hold time of 106 days.

More News

Anteris gets German clearance to expand global PARADIGM heart valve trial, boosting patient recruitment.

Anteris gets German clearance to expand global PARADIGM heart valve trial, boosting patient recruitment.

Anteris Technologies received regulatory approval from Germany's BfArM to start enrolling patients in its global PARADIGM trial for the DurAVR Transcatheter Heart Valve. This approval allows the company to recruit patients at leading German centers, ...

Market News
Bullish
1 hour ago
XBiotech's phase II trial shows 61.3% 12-month survival in refractory metastatic colorectal cancer with vilamakitug.

XBiotech's phase II trial shows 61.3% 12-month survival in refractory metastatic colorectal cancer with vilamakitug.

XBiotech announced positive final efficacy results from its phase II TASKIN trial for vilamakitug (XB2001) in refractory metastatic colorectal cancer. The study, funded by the French National Cancer Institute, showed a 61.3% overall survival rate at ...

Company Fundamentals
Bullish
4 hours ago
Phase II study shows Vilamakitug improves 12-month survival in refractory metastatic colorectal cancer.

Phase II study shows Vilamakitug improves 12-month survival in refractory metastatic colorectal cancer.

XBiotech announced positive final results from the Phase II TASKIN study, showing that adding Vilamakitug (XB2001) to standard chemotherapy improved 12-month overall survival to 61.3% in patients with refractory metastatic colorectal cancer, surpassi...

Market News
Bullish
4 hours ago
Solana's non-vote transactions hit 8.92B in Q3 2026, up 104% from Q4 2025, setting new weekly and monthly records.

Solana's non-vote transactions hit 8.92B in Q3 2026, up 104% from Q4 2025, setting new weekly and monthly records.

Solana recorded 8.92 billion non-vote transactions from July to September 2026, marking a 104% increase compared to the fourth quarter of 2025. These transactions exclude validator votes and include activities like transfers, trading, and decentraliz...

Protocol Fundamentals
Bullish
4 hours ago
Jio Platforms' IPO anchor book oversubscribed 30x with $26.3B bids from top global investors

Jio Platforms' IPO anchor book oversubscribed 30x with $26.3B bids from top global investors

Jio Platforms, backed by Meta and Google, has seen its IPO anchor book oversubscribed over 30 times, attracting $26.3 billion in bids for an $854 million portion. The company aims to raise up to $3.2 billion in India's largest-ever IPO by rupee value...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App